方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| 头痛影响测试-6× | EORTC QLQ-C30：癌症生活质量评估的核心问卷× | |
|---|---|---|
| 领域 | 健康结局 | 健康结局 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 2003 | 1993 |
| 提出者≠ | Mark Kosinski et al. | Nico Aaronson et al. |
| 类型≠ | Self-report functional impact questionnaire | Self-report quality of life questionnaire |
| 开创性文献≠ | Kosinski, M., Bayliss, M. S., Bjorner, J. B., Ware, J. E., Garber, W. H., Batenhorst, A., & Tepper, S. (2003). A six-item short-form survey for measuring headache impact: The HIT-6. Quality of Life Research, 12(8), 963-974. DOI ↗ | Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., ... & Takeda, F. (1993). The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376. DOI ↗ |
| 别名 | HIT-6, Headache Impact Test, HIT | QLQ-C30, EORTC QLQ-C30, Cancer Quality of Life Scale |
| 相关≠ | 4 | 5 |
| 摘要≠ | The HIT-6 is a brief, validated measure of headache impact on daily functioning and quality of life. Developed by Mark Kosinski and colleagues in 2003, this 6-item questionnaire quantifies how headache (migraine or other types) affects work, social activities, sleep, and emotional well-being. It is widely used in headache research, clinical trials, and practice to assess disease burden and treatment benefit. | The EORTC QLQ-C30 is the most widely used international instrument for assessing quality of life in cancer patients. Developed by the European Organisation for Research and Treatment of Cancer in 1993, it measures physical, emotional, cognitive, and social functioning alongside cancer-specific symptoms and financial impact, making it the standard outcome measure in oncology clinical trials and patient care. |
| ScholarGate数据集 ↗ |
|
|